As shown in Table 1, high expression of TRPV3 remarkably affected the OS in ccRCC cases of Stage1/2/4, female and male, Grade2/3, and mutation burden high/low. This evidence concerns the gene TRPV3 and nonpapillary renal cell carcinoma.